FARI researchers continue to examine fatty acid and health relationships across a wide range of topics. The following studies are either currently in progress, planned or possible.  Examples of recent scientific publications from the FARI research team can be found here.

IN PROGRESS

• Is there a fatty acid “fingerprint” that can improve prediction for risk of death?
• Does a high Omega-3 Index increase risk for prostate cancer?
• Do fish oil supplements raise LDL-Cholesterol levels? 
• Is the Omega-3 Index favorably related with post-exercise heart rate recovery? 
• What is the effect of menopausal hormone therapy on the Omega-3 Index?
• Omega-3 index and Alzheimer’s Disease: risk markers and risk factors
• Omega-3 index as a predictor of risk for stroke
• Omega-3 and risk for adverse health outcomes in heart attack survivors
  
  
• FORCE (Fatty Acids & Outcomes Research Consortium) Collaborations
  • Omega-3 biomarkers and heart failure
  • Omega-3 and very long chain saturated fatty acid levels and risk for chronic kidney disease
  • Very long chain monounsaturated fatty acids and risk for heart failure
  • Omega-3 biomarkers and death from any cause
  • Omega-3 and quality of sleep
  • Omega-3 and trans fatty acid levels and incident Type 2 Diabetes
  • Dairy fat biomarkers and incident CVD

 
PLANNED
These projects all begin with “What is the relationship between blood levels of omega-3 (or other) fatty acids and …”

• Cardiovascular disease risk as compared to that for classical CVD risk factors?
• Death from Alzheimer’s disease and dementia?
• Success of in vitro fertilization/implantation?
• Classical and emerging cardiovascular risk factors such as LDL-cholesterol, triglycerides, HDL-cholesterol, red blood cell distribution width, vitamin D and multiple inflammatory molecules?

 
POSSIBLE
These projects all begin with “What is the relationship between blood levels of omega-3 (or other) fatty acids and …”

• Cognitive function in non-demented people?
• Cerebrospinal fluid markers of Alzheimer’s disease or brain/vascular function; neuroimaging (amyloid-PET; glucose metabolism); and cognition.
• Age-related hearing loss?
• Age-related macular degeneration?
• Frailty? Muscle mass? Balance?
• Biochemical markers of “aging” (e.g., telomere attrition rates, DNA methylation and DNA breakdown)?
• Psychosis?
• Ischemic stroke?
• Multiple types of cancer?
• Glaucoma?
• Vascular function?
• Risk for bleeding?
• ​Fatty liver?
  
• Lung function and resistance to airborne pollutants?
• Smoking on risk for a CVD and cancer?
• Strength, performance and recovery from exercise?
• Bone and joint health; need for joint replacements?
• Periodontal health?